Logo image of ATEC

ALPHATEC HOLDINGS INC (ATEC) Stock Fundamental Analysis

NASDAQ:ATEC - Nasdaq - US02081G2012 - Common Stock - Currency: USD

12.27  -0.26 (-2.08%)

After market: 11.1 -1.17 (-9.54%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to ATEC. ATEC was compared to 188 industry peers in the Health Care Equipment & Supplies industry. Both the profitability and financial health of ATEC have multiple concerns. While showing a medium growth rate, ATEC is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year ATEC has reported negative net income.
ATEC had a negative operating cash flow in the past year.
ATEC had negative earnings in each of the past 5 years.
In the past 5 years ATEC always reported negative operating cash flow.
ATEC Yearly Net Income VS EBIT VS OCF VS FCFATEC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -50M -100M -150M

1.2 Ratios

Looking at the Return On Assets, with a value of -20.90%, ATEC is in line with its industry, outperforming 51.08% of the companies in the same industry.
ATEC's Return On Equity of -1718.50% is on the low side compared to the rest of the industry. ATEC is outperformed by 90.86% of its industry peers.
Industry RankSector Rank
ROA -20.9%
ROE -1718.5%
ROIC N/A
ROA(3y)-24.42%
ROA(5y)-25.75%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ATEC Yearly ROA, ROE, ROICATEC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1K -1K

1.3 Margins

ATEC has a Gross Margin of 69.37%. This is in the better half of the industry: ATEC outperforms 78.49% of its industry peers.
In the last couple of years the Gross Margin of ATEC has remained more or less at the same level.
ATEC does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 69.37%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.25%
GM growth 5Y0.27%
ATEC Yearly Profit, Operating, Gross MarginsATEC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100

More info and screens

2

2. Health

2.1 Basic Checks

ATEC does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for ATEC remains at a similar level compared to 1 year ago.
ATEC has more shares outstanding than it did 5 years ago.
ATEC has a worse debt/assets ratio than last year.
ATEC Yearly Shares OutstandingATEC Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
ATEC Yearly Total Debt VS Total AssetsATEC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

Based on the Altman-Z score of -0.25, we must say that ATEC is in the distress zone and has some risk of bankruptcy.
ATEC has a Altman-Z score (-0.25) which is comparable to the rest of the industry.
ATEC has a Debt/Equity ratio of 60.90. This is a high value indicating a heavy dependency on external financing.
Looking at the Debt to Equity ratio, with a value of 60.90, ATEC is doing worse than 90.86% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 60.9
Debt/FCF N/A
Altman-Z -0.25
ROIC/WACCN/A
WACC8.29%
ATEC Yearly LT Debt VS Equity VS FCFATEC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M

2.3 Liquidity

ATEC has a Current Ratio of 2.73. This indicates that ATEC is financially healthy and has no problem in meeting its short term obligations.
ATEC has a Current ratio of 2.73. This is comparable to the rest of the industry: ATEC outperforms 48.39% of its industry peers.
ATEC has a Quick Ratio of 1.58. This is a normal value and indicates that ATEC is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.58, ATEC is doing worse than 60.75% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.73
Quick Ratio 1.58
ATEC Yearly Current Assets VS Current LiabilitesATEC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

More info and screens

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 26.45% over the past year.
Looking at the last year, ATEC shows a very strong growth in Revenue. The Revenue has grown by 26.81%.
ATEC shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 40.08% yearly.
EPS 1Y (TTM)26.45%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%37.84%
Revenue 1Y (TTM)26.81%
Revenue growth 3Y35.99%
Revenue growth 5Y40.08%
Sales Q2Q%28.14%

3.2 Future

Based on estimates for the next years, ATEC will show a very strong growth in Earnings Per Share. The EPS will grow by 37.50% on average per year.
Based on estimates for the next years, ATEC will show a quite strong growth in Revenue. The Revenue will grow by 15.21% on average per year.
EPS Next Y42.88%
EPS Next 2Y33.67%
EPS Next 3Y37.5%
EPS Next 5YN/A
Revenue Next Year20.37%
Revenue Next 2Y19.51%
Revenue Next 3Y18.37%
Revenue Next 5Y15.21%

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
ATEC Yearly Revenue VS EstimatesATEC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 200M 400M 600M 800M 1B
ATEC Yearly EPS VS EstimatesATEC Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 0.5 -0.5 -1 -1.5

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

ATEC reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year ATEC is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ATEC Price Earnings VS Forward Price EarningsATEC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ATEC Per share dataATEC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 2 3 4

4.3 Compensation for Growth

ATEC's earnings are expected to grow with 37.50% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y33.67%
EPS Next 3Y37.5%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for ATEC!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ALPHATEC HOLDINGS INC

NASDAQ:ATEC (3/3/2025, 4:17:35 PM)

After market: 11.1 -1.17 (-9.54%)

12.27

-0.26 (-2.08%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)02-26 2025-02-26/amc
Earnings (Next)05-05 2025-05-05/amc
Inst Owners60.14%
Inst Owner Change0.47%
Ins Owners10.93%
Ins Owner Change4.27%
Market Cap1.74B
Analysts82.22
Price Target17.79 (44.99%)
Short Float %9.89%
Short Ratio6.91
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-12.44%
Min EPS beat(2)-15.38%
Max EPS beat(2)-9.49%
EPS beat(4)0
Avg EPS beat(4)-8.72%
Min EPS beat(4)-15.38%
Max EPS beat(4)-3.28%
EPS beat(8)0
Avg EPS beat(8)-21.83%
EPS beat(12)0
Avg EPS beat(12)-22.1%
EPS beat(16)0
Avg EPS beat(16)-28.72%
Revenue beat(2)2
Avg Revenue beat(2)0.43%
Min Revenue beat(2)0.37%
Max Revenue beat(2)0.48%
Revenue beat(4)3
Avg Revenue beat(4)0.23%
Min Revenue beat(4)-1.23%
Max Revenue beat(4)1.29%
Revenue beat(8)7
Avg Revenue beat(8)1.62%
Revenue beat(12)11
Avg Revenue beat(12)2.82%
Revenue beat(16)15
Avg Revenue beat(16)4.68%
PT rev (1m)0%
PT rev (3m)3.63%
EPS NQ rev (1m)-0.74%
EPS NQ rev (3m)-4.91%
EPS NY rev (1m)0%
EPS NY rev (3m)-0.92%
Revenue NQ rev (1m)0.34%
Revenue NQ rev (3m)1.3%
Revenue NY rev (1m)0.17%
Revenue NY rev (3m)0.41%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 2.84
P/FCF N/A
P/OCF N/A
P/B 184.39
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-1.14
EYN/A
EPS(NY)-0.65
Fwd EYN/A
FCF(TTM)-0.97
FCFYN/A
OCF(TTM)-0.31
OCFYN/A
SpS4.31
BVpS0.07
TBVpS-1.09
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -20.9%
ROE -1718.5%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 69.37%
FCFM N/A
ROA(3y)-24.42%
ROA(5y)-25.75%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.25%
GM growth 5Y0.27%
F-Score5
Asset Turnover0.79
Health
Industry RankSector Rank
Debt/Equity 60.9
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 118.77%
Cap/Sales 15.23%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.73
Quick Ratio 1.58
Altman-Z -0.25
F-Score5
WACC8.29%
ROIC/WACCN/A
Cap/Depr(3y)138.42%
Cap/Depr(5y)170.73%
Cap/Sales(3y)16.62%
Cap/Sales(5y)18.8%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)26.45%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%37.84%
EPS Next Y42.88%
EPS Next 2Y33.67%
EPS Next 3Y37.5%
EPS Next 5YN/A
Revenue 1Y (TTM)26.81%
Revenue growth 3Y35.99%
Revenue growth 5Y40.08%
Sales Q2Q%28.14%
Revenue Next Year20.37%
Revenue Next 2Y19.51%
Revenue Next 3Y18.37%
Revenue Next 5Y15.21%
EBIT growth 1Y17.14%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year294.03%
EBIT Next 3Y89.32%
EBIT Next 5Y64.84%
FCF growth 1Y16.72%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y43.11%
OCF growth 3YN/A
OCF growth 5YN/A